For a patient with orbital sarcoidosis who has achieved sustained clinical remission on adalimumab in combination with mycophenolate mofetil, how long would you recommend continuing mycophenolate before considering a gradual taper and discontinuation?

In patients with sarcoidosis who achieve remission, I generally favor considering a gradual taper of immunosuppressive therapy after sustained disease control, rather than discontinuing treatment immediately once clinical remission is achieved.

There is no universally accepted duration of remission o...